6 citations,
November 1980 in “Clinical Endocrinology” Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.
5 citations,
January 2015 in “Evidence-based complementary and alternative medicine” Adding licorice gel to laser treatment is more effective for reducing facial hair than laser alone.
5 citations,
June 2012 in “Journal of Cosmetic and Laser Therapy” Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.
4 citations,
January 2015 in “Journal of drug assessment” Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.
4 citations,
January 1999 in “PubMed” 2 citations,
June 2004 in “Expert review of pharmacoeconomics & outcomes research” Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.
February 2013 in “Journal of The American Academy of Dermatology” There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.
January 2013 in “International journal of contemporary surgery” Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.
December 1999 in “Evidence-based obstetrics and gynecology/Evidence-based obstetrics & gynecology” Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.
September 1997 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” Spironolactone is more effective than finasteride in treating excessive hair growth in women.
November 1982 in “Inpharma” Spironolactone reduces hair growth in women with unexplained excessive hairiness.
June 2018 in “American journal of biomedicine” Topical finasteride cream reduces hair growth perception in women with idiopathic hirsutism.
39 citations,
November 1978 in “Annals of internal medicine” Spironolactone may help reduce excessive hair growth in women with high male hormone levels.
24 citations,
September 1995 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism” Medication and hair removal methods can improve hirsutism, but no drugs were specifically approved for it in North America as of 1995.
8 citations,
January 1998 in “PubMed” 3 citations,
November 2005 in “Journal of Research in Medical Sciences” 
December 2023 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” Many women in Turkey have hirsutism, according to the research group's findings.
December 1990 in “PubMed” 
24 citations,
March 2002 in “Expert opinion on investigational drugs” Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.
2 citations,
August 1999 in “PubMed” 1 citations,
November 1996 in “Obstetrical & Gynecological Survey” January 2022 in “Springer eBooks” 3 citations,
June 1996 in “PubMed” 1 citations,
July 2021 in “DOAJ (DOAJ: Directory of Open Access Journals)” 
The text is about acne, excessive hair growth, and hair loss due to hormones.
January 1986 in “Journal of Steroid Biochemistry” Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.
September 2015 in “American journal of biomedicine” 
19 citations,
July 1990 in “Cleveland Clinic journal of medicine” Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.
18 citations,
October 2015 in “Journal of the European Academy of Dermatology and Venereology” This study investigated the effectiveness of topical eflornithine in maintaining hair reduction in women with facial hirsutism following intense pulsed light (IPL) therapy. Conducted as a randomized, split-face, single-blinded controlled trial, it involved 22 women, with 18 completing the study. Eflornithine was applied twice daily for 6 months to half of the face after 5-6 IPL treatments. Results showed that eflornithine reduced hair regrowth by 14% at 1 month, 9% at 3 months, and 17% at 6 months compared to no treatment. Patients reported satisfaction with the treatment, although two experienced worsening acne. Overall, eflornithine was well tolerated and showed potential as a self-administered option to maintain IPL-induced hair reduction.